LONDON--(BUSINESS WIRE)--

FORM 8.3

AMENDMENTS

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the 'Code')

1. KEY INFORMATION

(a) Full name of discloser: Barclays PLC.
(b) Owner or controller of interest and short
positions disclosed, if different from 1(a):
(c) Name of offeror/offeree in relation to whose TAKEDA PHARMACEUTICAL CO LTD
relevant securities this form relates:
(d) If an exempt fund manager connected with an
offeror/offeree, state this and specify identity of
offeror/offeree:
(e) Date position held/dealing undertaken: 18 April 2018
(f) In addition to the company in 1(c) above, is the discloser making YES:
disclosures in respect of any other party to the offer? SHIRE PLC

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security: ORD
Interests Short Positions
Number (%) Number (%)
(1) Relevant securities owned
and/or controlled: 14,048,854 1.77% 13,776,512 1.73%
(2) Cash-settled derivatives:
13,484,793 1.70% 13,438,300 1.69%
(3) Stock-settled derivatives (including options)
and agreements to purchase/sell: 13,461,700 1.69% 13,881,700 1.75%
(4)
TOTAL: 40,995,347 5.16% 41,096,512 5.17%

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

(b) Rights to subscribe for new securities (including directors' and other employee options)

Class of relevant security in relation to which subscription right exists:
Details, including nature of the rights concerned and relevant percentages:

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a) Purchases and sales

Class of relevant Purchase/sale Number of Price per unit
security securities
ORD Purchase 100 5,122.0000 JPY
ORD Purchase 100 5,106.0000 JPY
ORD Purchase 800 5,112.7500 JPY
ORD Purchase 900 5,100.4444 JPY
ORD Purchase 900 5,101.2222 JPY
ORD Purchase 1,700 5,108.4705 JPY
ORD Purchase 1,900 5,105.0000 JPY
ORD Purchase 3,000 5,103.9666 JPY
ORD Purchase 3,900 5,104.5384 JPY
ORD Purchase 6,600 5,105.2424 JPY
ORD Purchase 8,000 5,106.2250 JPY
ORD Purchase 9,400 5,110.9042 JPY
ORD Purchase 13,500 5,100.0000 JPY
ORD Purchase 17,100 5,105.5964 JPY
ORD Purchase 30,900 5,098.0000 JPY
ORD Purchase 43,800 5,104.7009 JPY
ORD Purchase 123,000 5,107.0130 JPY
ORD Purchase 181,000 5,106.3497 JPY
ORD Sale 100 5,098.0000 JPY
ORD Sale 200 5,110.5000 JPY
ORD Sale 300 5,108.6666 JPY
ORD Sale 400 5,101.2500 JPY
ORD Sale 500 5,102.8000 JPY
ORD Sale 700 5,107.8571 JPY
ORD Sale 800 5,101.6250 JPY
ORD Sale 800 5,112.7500 JPY
ORD Sale 1,700 5,108.4705 JPY
ORD Sale 5,900 5,116.5423 JPY
ORD Sale 6,600 5,105.2424 JPY
ORD Sale 7,300 5,114.2465 JPY
ORD Sale 8,100 5,118.7284 JPY
ORD Sale 8,500 5,106.1529 JPY
ORD Sale 12,200 5,100.0655 JPY
ORD Sale 123,300 5,106.4428 JPY
ORD Sale 281,600 5,106.1757 JPY

(b) Cash-settled derivative transactions

Class of Product Nature of dealing Number of Price per
relevant description reference unit
security securities
ORD CFD Long 3,900 5,121.4879 JPY
ORD SWAP Short 27,900 5,098.0000 JPY

(c) Stock-settled derivative transactions (including options)

(i) Writing, selling, purchasing or varying

Class of relevant security Product description e.g. call option Writing, purchasing, selling, varying etc. Number of securities to which option relates Exercise price per unit Type

e.g. American, European etc.

 Expiry date Option money paid/ received per unit

(ii) Exercise

Class of relevant security Product description

e.g. call option

 Exercising/ exercised against Number of securities Exercise price per unit

(d) Other dealings (including subscribing for new securities)

Class of relevant security Nature of dealing

e.g. subscription, conversion

 Details Price per unit (if applicable)

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state 'none'

None

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state 'none'

None

(c) Attachments

Is a Supplemental Form 8 (Open Positions) attached? YES
Date of disclosure: 19 Apr 2018
Contact name: ELISE TANG
Telephone number: 0207 1163001

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel's website atwww.thetakeoverpanel.org.uk.

SUPPLEMENTAL FORM 8 (OPEN POSITIONS)

DETAILS OF OPEN STOCK-SETTLED DERIVATIVE (INCLUDING OPTION) POSITIONS, AGREEMENTS TO PURCHASE OR SELL ETC.

Note 5(i) on Rule 8 of the Takeover Code (the 'Code')

1. KEY INFORMATION

Identity of the person whose positions/dealings Barclays PLC.
are being disclosed:
Name of offeror/offeree in relation to whose TAKEDA PHARMACEUTICAL CO LTD
relevant securities this from relates:

2. STOCK-SETTLED DERIVATIVES (INCLUDING OPTIONS)

Class Product Writing, Number Exercise Type Expiry
of description purchasing, of price date
relevant selling, securities per unit
security varying etc to which
option
relates
ORD Put Options Purchased -39,000 5781.0000 European 14 Dec 2018
ORD Call Options Purchased 40,000 6182.0000 European 14 Dec 2018
ORD Call Options Purchased 39,000 5781.0000 European 14 Dec 2018
ORD Call Options Written -78,000 5781.0000 European 14 Dec 2018
ORD Call Options Written -460,000 6182.0000 European 14 Dec 2018
ORD Call Options Purchased 13,200,000 5340.9555 European 7 May 2018
ORD Call Options Written -104,700 5065.8300 European 17 Apr 2019
ORD Put Options Purchased -13,200,000 5340.9555 European 7 May 2018
ORD Put Options Written 104,700 5065.8300 European 17 Apr 2019
ORD Put Options Written 13,200,000 5340.9555 European 7 May 2018
ORD Put Options Written 78,000 5781.0000 European 14 Dec 2018
ORD Call Options Written -13,200,000 5340.9555 European 7 May 2018

3. AGREEMENTS TO PURCHASE OR SELL ETC.

Full details should be given so that the nature of the interest or position can be fully understood:

It is not necessary to provide details on a Supplemental Form (Open Positions) with regard to cash-settled derivatives.

The currency of all prices and other monetary amounts should be stated.

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel's website atwww.thetakeoverpanel.org.uk.

View source version on businesswire.com:https://www.businesswire.com/news/home/20180419006171/en/

BARCLAYS PLC

Source: BARCLAYS PLC

Attachments

  • Original document
  • Permalink

Disclaimer

Barclays plc published this content on 19 April 2018 and is solely responsible for the information contained herein. Distributed by Public, unedited and unaltered, on 19 April 2018 17:01:04 UTC